Total Payments
$4,753
2024 Payments
$910.32
Companies
44
Transactions
289
Medicare Patients
4,682
Medicare Billing
$344,525
Payment Breakdown by Category
Food & Beverage$4,753 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,753 | 289 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $701.22 | 43 | $0 (2024) |
| ABBVIE INC. | $663.87 | 43 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $451.71 | 31 | $0 (2024) |
| Novo Nordisk Inc | $446.72 | 32 | $0 (2024) |
| Lilly USA, LLC | $412.56 | 24 | $0 (2024) |
| GlaxoSmithKline, LLC. | $232.79 | 12 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $217.55 | 11 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $201.19 | 12 | $0 (2023) |
| Allergan, Inc. | $141.54 | 10 | $0 (2020) |
| Biohaven Pharmaceutical Holding Company Ltd. | $133.37 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $910.32 | 45 | PFIZER INC. ($168.11) |
| 2023 | $865.25 | 48 | AbbVie Inc. ($196.27) |
| 2022 | $787.84 | 51 | ABBVIE INC. ($173.76) |
| 2021 | $864.54 | 59 | PFIZER INC. ($190.56) |
| 2020 | $632.64 | 38 | PFIZER INC. ($149.55) |
| 2019 | $300.58 | 19 | AstraZeneca Pharmaceuticals LP ($105.30) |
| 2018 | $381.00 | 28 | PFIZER INC. ($88.31) |
| 2017 | $10.60 | 1 | AstraZeneca Pharmaceuticals LP ($10.60) |
All Payment Transactions
289 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: PAIN | ||||||
| 11/27/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Diabetes Care | ||||||
| 11/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Inflammation | ||||||
| 10/31/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: PAIN | ||||||
| 10/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $31.03 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: PSYCHIATRY | ||||||
| 10/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: DIABETES | ||||||
| 10/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: PSYCHIATRY | ||||||
| 09/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: PAIN | ||||||
| 09/23/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Insomnia | ||||||
| 09/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: RESPIRATORY | ||||||
| 09/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: PSYCHIATRY | ||||||
| 09/09/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $29.70 | General |
| Category: RESPIRATORY | ||||||
| 08/27/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: PAIN | ||||||
| 08/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Inflammation | ||||||
| 07/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: NEUROSCIENCE | ||||||
| 07/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: PAIN | ||||||
| 07/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: Obesity | ||||||
| 06/20/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Insomnia | ||||||
| 06/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Inflammation | ||||||
| 06/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Diabetes | ||||||
| 05/21/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $26.72 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,245 | 1,438 | $201,551 | $98,793 |
| 2022 | 14 | 1,371 | 1,586 | $204,770 | $104,279 |
| 2021 | 13 | 1,116 | 1,306 | $151,992 | $79,349 |
| 2020 | 13 | 950 | 1,121 | $141,193 | $62,104 |
Total Patients
4,682
Total Services
5,451
Medicare Billing
$344,525
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 331 | 331 | $53,410 | $40,183 | 75.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 274 | 403 | $73,979 | $31,926 | 43.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 115 | 138 | $17,158 | $6,760 | 39.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 41 | 41 | $19,926 | $6,393 | 32.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 28 | 28 | $9,128 | $4,374 | 47.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 36 | 36 | $5,260 | $2,511 | 47.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 37 | 37 | $6,460 | $2,171 | 33.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 238 | 250 | $6,000 | $2,092 | 34.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 37 | 37 | $1,258 | $1,039 | 82.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 59 | 81 | $6,156 | $754.18 | 12.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 13 | 13 | $1,612 | $495.52 | 30.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 36 | 43 | $1,204 | $94.60 | 7.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 319 | 319 | $50,083 | $39,547 | 79.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 296 | 415 | $70,965 | $33,295 | 46.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 145 | 178 | $20,292 | $9,392 | 46.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 34 | 34 | $11,084 | $5,422 | 48.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 34 | 34 | $16,524 | $5,420 | 32.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 40 | 41 | $5,320 | $2,807 | 52.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 38 | 38 | $6,536 | $2,730 | 41.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 14 | $3,276 | $1,794 | 54.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 39 | 40 | $1,360 | $1,087 | 80.0% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 74 | 107 | $8,132 | $1,085 | 13.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 265 | 284 | $6,816 | $848.77 | 12.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 21 | 21 | $2,604 | $661.20 | 25.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 41 | 47 | $1,316 | $104.55 | 7.9% |
About Dr. Margaret Carter, M.D
Dr. Margaret Carter, M.D is a Family Medicine healthcare provider based in Saint Simons Island, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184638702.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Margaret Carter, M.D has received a total of $4,753 in payments from pharmaceutical and medical device companies, with $910.32 received in 2024. These payments were reported across 289 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($4,753).
As a Medicare-enrolled provider, Carter has provided services to 4,682 Medicare beneficiaries, totaling 5,451 services with total Medicare billing of $344,525. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Saint Simons Island, GA
- Active Since 07/28/2006
- Last Updated 12/31/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1184638702
Products in Payments
- VRAYLAR (Drug) $433.64
- NURTEC ODT (Drug) $320.70
- UBRELVY (Drug) $238.13
- REXULTI (Drug) $232.36
- FARXIGA (Drug) $205.72
- CHANTIX (Drug) $169.26
- EMGALITY (Drug) $155.89
- TRINTELLIX (Drug) $143.67
- BYDUREON (Drug) $143.57
- JARDIANCE (Drug) $135.49
- Wegovy (Drug) $134.72
- Ozempic (Drug) $117.03
- Rybelsus (Drug) $110.15
- AREXVY (Drug) $98.22
- PREMARIN (Drug) $91.95
- MOUNJARO (Drug) $89.09
- Otezla (Drug) $87.04
- QUVIVIQ (Drug) $83.55
- TRULICITY (Drug) $80.74
- TRELEGY ELLIPTA (Drug) $80.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.